US7909754B2 - Non-invasive measurement of fluid pressure in an adjustable gastric band - Google Patents

Non-invasive measurement of fluid pressure in an adjustable gastric band Download PDF

Info

Publication number
US7909754B2
US7909754B2 US11/065,407 US6540705A US7909754B2 US 7909754 B2 US7909754 B2 US 7909754B2 US 6540705 A US6540705 A US 6540705A US 7909754 B2 US7909754 B2 US 7909754B2
Authority
US
United States
Prior art keywords
pressure
restriction
working fluid
food intake
fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US11/065,407
Other versions
US20060189887A1 (en
Inventor
William L. Hassler, Jr.
Russell L. Holscher
Lauren S. Perry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Endo Surgery Inc
Original Assignee
Ethicon Endo Surgery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Endo Surgery Inc filed Critical Ethicon Endo Surgery Inc
Priority to US11/065,407 priority Critical patent/US7909754B2/en
Assigned to ETHICON ENDO-SURGERY, INC. reassignment ETHICON ENDO-SURGERY, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HASSLER, JR., WILLIAM L., HOLSCHER, RUSSELL L., PERRY, LAUREN S.
Publication of US20060189887A1 publication Critical patent/US20060189887A1/en
Priority to US13/023,729 priority patent/US20110130626A1/en
Application granted granted Critical
Publication of US7909754B2 publication Critical patent/US7909754B2/en
Expired - Fee Related legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices

Definitions

  • the present invention is related generally to a food intake restriction device for the treatment of morbid obesity and, more particularly, to a non-invasive method of determining the fluid pressure within an adjustable gastric band.
  • the present invention relates to incorporating a pressure sensor within an adjustable gastric band to measure the pressure of a working fluid within the band, and non-invasively communicating the pressure measurement to an external monitor.
  • Obesity is becoming a growing concern, particularly in the United States, as the number of obese people continues to increase, and more is learned about the negative health effects of obesity.
  • Morbid obesity in which a person is 100 pounds or more over ideal body weight, in particular poses significant risks for severe health problems. Accordingly, a great deal of attention is being focused on treating obese patients.
  • One method of treating morbid obesity has been to place a restriction device, such as an elongated band, about the upper portion of the stomach. The band is placed so as to form a small gastric pouch above the band and a reduced stoma opening in the stomach. The effect of the band is to reduce the available stomach volume and, thus, the amount of food that can be consumed before becoming “full”.
  • Gastric bands have typically comprised a fluid-filled elastomeric balloon with fixed endpoints that encircles the stomach just inferior to the esophago-gastric junction.
  • the band expands against the stomach, creating a food intake restriction or stoma in the stomach. To decrease this restriction, fluid is removed from the band.
  • Food restriction devices have also comprised mechanically adjusted bands that similarly encircle the upper portion of the stomach. These bands include any number of resilient materials or gearing devices, as well as drive members, for adjusting the bands. Additionally, gastric bands have been developed that include both hydraulic and mechanical drive elements. An example of such an adjustable gastric band is disclosed in U.S. Pat. No. 6,067,991, entitled “Mechanical Food Intake Restriction Device” which issued on May 30, 2000, and is incorporated herein by reference. It is also known to restrict the available food volume in the stomach cavity by implanting an inflatable elastomeric balloon within the stomach cavity itself. The balloon is filled with a fluid to expand against the stomach walls and, thereby, decrease the available food volume within the stomach.
  • the device With each of the above-described food restriction devices, safe, effective treatment requires that the device be regularly monitored and adjusted to vary the degree of restriction applied to the stomach.
  • banding devices the gastric pouch above the band will substantially increase in size following the initial implantation. Accordingly, the stoma opening in the stomach must initially be made large enough to enable the patient to receive adequate nutrition while the stomach adapts to the banding device.
  • the band may be adjusted to vary the stoma size.
  • adjusting a hydraulic gastric band required a scheduled clinician visit during which a hypodermic needle and syringe were used to permeate the patient's skin and add or remove fluid from the balloon.
  • implantable pumps have been developed which enable non-invasive adjustments of the band.
  • An external programmer communicates with the implanted pump using telemetry to control the pump.
  • a physician places a hand-held portion of the programmer near the gastric implant and transmits power and command signals to the implant.
  • the implant in turn adjusts the fluid levels in the band and transmits a response command to the programmer.
  • a physician may simply adopt a “try as you go” method based upon their prior experience, and the results of an adjustment may not be discovered until hours or days later, when the patient experiences a complete obstruction of the stomach cavity, or the band induces erosion of the stomach tissue.
  • a gastric restriction device that includes a pressure measuring system for measuring the pressure within the restriction device and, accordingly, the stoma size.
  • a non-invasive method for measuring fluid pressure during an adjustment and communicating the pressure measurement to an external monitor.
  • the present invention provides a method for non-invasively measuring the pressure of a fluid inside an implanted food intake restriction device.
  • the method includes implanting a food intake restriction device in the gastro-intestinal tract of a patient and using a working fluid in the restriction device to form a restricted opening in the gastro-intestinal tract.
  • the pressure in the restricted opening is determined by measuring the pressure of the working fluid with a pressure sensor in communication with the working fluid.
  • An external monitor is placed adjacent to the pressure sensor. A measured pressure signal is transmitted from the pressure sensor to the external monitor and displayed on an external display.
  • the present invention provides a food intake restriction system for forming a restriction in a patient's gastro-intestinal tract and non-invasively communicating pressure data regarding the restriction to an external monitor.
  • the system includes a food intake restriction device implanted to form a restriction in the patient's gastro-intestinal tract.
  • a port is connected to the restriction device.
  • the port contains a working fluid for affecting the size of the restricted opening.
  • a pressure sensing system communicates with the working fluid to measure the pressure of the working fluid.
  • a transmitter communicates the measured fluid pressure to the external monitor.
  • the present invention provides an implanted bariatric treatment device for forming a food intake restriction in a patient's stomach and communicating the pressure of the restriction to an external monitor.
  • the device includes a restriction member implanted in contact with the patient's stomach.
  • the restriction member has a variable fluid volume to create a food intake restriction in the stomach.
  • a control is operatively connected to the restriction member to vary the volume of the restriction member.
  • a pressure sensing system measures the fluid pressure within the restriction member, and non-invasively communicates the measured pressure to the external monitor. The fluid pressure measurement is proportional to the degree of restriction formed in the stomach.
  • FIG. 1 is a schematic illustration of a food intake restriction device of the present invention
  • FIG. 2 is a more detailed perspective view of an exemplary implantable portion for the food intake restriction device of FIG. 1 ;
  • FIG. 3 is a perspective view of the adjustable gastric band of FIG. 2 , showing the band positioned around the gastro-esophageal junction of a patient;
  • FIG. 4 is a sectional view of the adjustable gastric band of FIG. 2 , shown in a deflated configuration
  • FIG. 5 is a sectional view of the adjustable gastric band of FIG. 2 , shown in an inflated configuration to create a food intake restriction;
  • FIG. 6 is a side, partially sectioned view of the injection port shown in FIG. 2 ;
  • FIG. 7 is an isometric view of the retaining cover shown in FIG. 6 ;
  • FIG. 8 is an isometric view of the pressure sensor shown in FIG. 6 ;
  • FIG. 9 is a side sectional view illustrating a first embodiment for the pressure sensing system of the present invention.
  • FIG. 10 is a simplified schematic of the variable resistance circuit of the first embodiment
  • FIG. 11 is a side, sectional view of a second embodiment for the pressure sensing system of the invention.
  • FIG. 12 is a block diagram representing a pressure measurement system associated with the first and second embodiments of the invention.
  • FIG. 13 is a side, sectional view of a third embodiment for the pressure sensing system of the invention.
  • FIG. 14 is a block diagram representing a pressure measurement system associated with the third embodiment of the invention.
  • FIG. 15 is a side, sectional view of a fourth embodiment for the pressure sensing system of the invention.
  • FIG. 16 is a side, sectional view of a fifth embodiment of the pressure sensing system of the invention.
  • FIG. 17 is a block diagram of a pressure measurement system associated with the fourth and fifth embodiments of the invention.
  • FIG. 18 is a graph indicating a pressure signal from the pressure sensing system, such as may appear on the external monitor display during interrogation by a user.
  • FIG. 1 illustrates a food intake restriction system 30 .
  • System 30 comprises a first portion, identified generally as 32 , implanted inside of a patient 34 , and a second portion, identified generally as 36 , located external to the patient.
  • Implanted portion 32 comprises an adjustable gastric band 38 positioned on the upper portion of the patient's stomach 40 .
  • Adjustable band 38 may include a cavity made of silicone rubber, or another type of biocompatible material, that inflates inwardly against stomach 40 when filled with a fluid.
  • band 38 may comprise a mechanically adjustable device having a fluid cavity that experiences pressure changes with band adjustments, or a combination hydraulic/mechanical adjustable band.
  • An injection port 42 which will be described in greater detail below, is implanted in a body region accessible for needle injections and/or telemetry communication signals.
  • injection port 42 fluidly communicates with adjustable band 38 via a catheter 44 .
  • a surgeon may position and permanently implant injection port 42 inside the body of the patient in order to perform adjustments of the food intake restriction or stoma.
  • gastric band systems such as implantable portion 32 have evolved greatly during recent years so that the patient may derive optimal therapeutic effect with minimal complications.
  • the surgeon typically implants injection port 42 in the lateral, subcostal region of the patient's abdomen under the skin and layers of fatty tissue.
  • the surgeon may also implant injection port 42 on the sternum of the patient.
  • FIG. 2 illustrates an exemplary adjustable gastric band in greater detail.
  • band 38 includes a variable volume cavity 46 that expands or contracts against the outer wall of the stomach to form an adjustable stoma for controllably restricting food intake into the stomach.
  • a physician may decrease the size of the stoma opening by adding fluid to variable volume cavity 46 or, alternatively, may increase the stoma size by withdrawing fluid from the cavity. Fluid may be added or withdrawn by inserting a needle into injection port 42 . Alternatively, fluid may be transferred in a non-invasive manner between band 38 and injection port 42 using telemetry command signals.
  • the fluid may be, but is not restricted to, a 0.9 percent saline solution.
  • FIG. 3 shows the adjustable gastric band 38 of FIG. 2 applied about the gastro-esophageal junction of a patient.
  • band 38 at least substantially encloses the upper portion of stomach 40 near the junction with esophagus 48 .
  • FIG. 4 is a sectional view of band 38 , showing the band in a deflated configuration. In this view, band 38 contains little to no fluid, thereby maximizing the size of the stoma opening into stomach 40 .
  • FIG. 5 is a cross-sectional view of band 38 and stomach 40 , similar to FIG. 4 , showing band 38 in an inflated, fluid-filled configuration.
  • FIG. 5 also schematically illustrates the dilation of esophagus 48 above band 38 to form an upper pouch 50 beneath the diaphragm muscle 52 of the patient.
  • external portion 36 of food restriction system 30 comprises a pressure-reading device 60 electrically connected (in this embodiment via an electrical cable assembly 62 ) to a control box 64 .
  • Control box 64 includes a display 66 , one or more control switches 68 , and an external control module, which will be explained in further detail below.
  • Control box 64 may be configured for use, for example, in a physician's office or examination room. Some ways to mount control box 64 include placement upon a desktop, attachment to an examination table, or hanging on a portable stand. Control box 64 may also be configured for carrying in the physician's lab coat pocket, holding by hand, or placing upon the examination table or the reclining patient.
  • Electrical cable assembly 62 may be detachably connected to control box 64 or pressure-reading device 60 to facilitate cleaning, maintenance, usage, and storage of external portion 36 of system 30 .
  • Pressure-reading device 60 non-invasively measures the pressure of the fluid within implanted portion 32 even when injection port 42 is implanted beneath thick (at least over 10 centimeters) subcutaneous fat tissue. The physician may hold pressure-reading device 60 against the patient's skin near the location of injection port 42 in the patient and observe the pressure reading on display 66 of control box 64 .
  • Pressure-reading device 60 may also be removably attached to the patient, such as during a prolonged examination, using straps, adhesives, and other well-known methods. Pressure-reading device 60 operates through conventional cloth or paper surgical drapes, and may also include a disposal cover (not shown) that may be replaced for each patient.
  • injection port 42 comprises a rigid housing 70 having an annular flange 72 containing a plurality of attachment holes 74 for fastening the injection port to tissue in a patient.
  • a surgeon may attach injection port 42 to the tissue, such as the fascia covering an abdominal muscle, using any one of numerous surgical fasteners including suture filaments, staples, and clips.
  • Injection port 42 further comprises a septum 76 typically made of a silicone rubber and compressively retained in housing 70 .
  • Septum 76 is penetrable by a Huber needle, or a similar type of injection instrument, for adding or withdrawing fluid from the port. Septum 76 self-seals upon withdrawal of the syringe needle to maintain the volume of fluid inside of injection port 42 .
  • Injection port 42 further comprises a reservoir 80 for retaining a working fluid and a catheter connector 82 .
  • Connector 82 attaches to catheter 44 , shown in FIG. 2 , to form a closed hydraulic circuit between reservoir 80 inside of injection port 42 and cavity 46 within adjustable band 38 .
  • Fluid from reservoir 80 may be used to expand the volume of band cavity 46 . Alternatively, fluid may be removed from cavity 46 and retained in reservoir 80 in order to temporarily decrease the volume of cavity 46 .
  • Housing 70 and connector 82 may be integrally molded from a biocompatible polymer or constructed from a metal such as titanium or stainless steel.
  • a pressure sensing system is provided in injection port 42 to measure the fluid pressure within the closed hydraulic circuit of implanted portion 32 .
  • the pressure within the circuit corresponds to the amount of restriction applied by adjustable band 38 to the patient's stomach. Accordingly, measuring the fluid pressure enables a physician to evaluate the restriction created by a band adjustment. Fluid pressure may be measured before, during and/or after an adjustment to verify that the band is properly adjusted.
  • the pressure sensing system comprises a sensor 84 positioned at the bottom of fluid reservoir 80 within housing 70 .
  • a retaining cover 86 extends above pressure sensor 84 to substantially separate the sensor surface from reservoir 80 , and protect the sensor from needle penetration.
  • Retaining cover 86 may be made of a ceramic material such as, for example, alumina, which resists needle penetration yet does not interfere with electronic communications between pressure sensor 84 and pressure-reading device 60 .
  • Retaining cover 86 includes a vent 90 that allows fluid inside of reservoir 80 to flow to and impact upon the surface of pressure sensor 84 .
  • FIG. 7 is an isometric view of retaining cover 86 illustrating vent 90 in the bottom surface of the cover.
  • FIG. 8 is an isometric view of the exterior of pressure sensor 84 .
  • the exterior of pressure sensor 84 includes a strain element having a deformable surface.
  • the strain element is a diaphragm 92 .
  • Diaphragm 92 may be formed by thinning out a section of a wall in titanium reservoir 80 .
  • Diaphragm 92 may be made of titanium or another similar material, and have a thickness between 0.001′′ and 0.002′′.
  • Pressure sensor 84 is hermetically sealed within a housing 94 to prevent fluid infiltrating and effecting the operation of the sensor. Housing 94 is sealed to port housing 70 to prevent the loss of fluid from the injection port 42 . Diaphragm 92 is hermetically sealed to sensor housing 94 to prevent fluid from passing around the edges of the diaphragm and into the internal components of the sensing system. As fluid flows through vent 90 in reservoir 80 , the fluid impacts upon the surface of diaphragm 92 . The fluid flow through vent 90 enables diaphragm 92 to respond to fluid pressure changes within the hydraulic circuit and convert the pressure changes into a mechanical displacement.
  • FIG. 9 is a side sectional view of pressure sensor 84 , taken along line A-A of FIG. 8 , illustrating a first embodiment 88 for measuring fluid pressure.
  • the mechanical displacement of diaphragm 92 is converted to an electrical signal by a pair of variable resistance, silicon strain gauges 96 , 98 .
  • Strain gauges 96 , 98 are attached to diaphragm 92 on the side opposite the working fluid in reservoir 80 .
  • Strain gauge 96 is attached to a center portion of diaphragm 92 to measure the displacement of the diaphragm.
  • the second, matched strain gauge 98 is attached near the outer edge of diaphragm 92 .
  • Strain gauges 96 , 98 may be attached to diaphragm 92 by adhesives, or may be diffused into the diaphragm structure. As the fluid pressure within band 38 changes, the surface of diaphragm 92 deforms up or down within the surface of housing 94 . This deformation of diaphragm 92 produces a resistance change in the center strain gauge 96 .
  • strain gauges 96 , 98 form the top two resistance elements of a half-compensated, Wheatstone bridge circuit 100 .
  • Strain gauge 98 is matched to strain gauge 96 and athermalizes the Wheatstone bridge circuit.
  • Differential amplifiers 102 , 104 are connected to bridge circuit 100 to measure the change in potential within the bridge circuit due to the variable resistance strain gauges. In particular, differential amplifier 102 measures the voltage across the entire bridge circuit, while differential amplifier 104 measures the differential voltage across the strain gauge half of bridge circuit 100 .
  • a fully compensated Wheatstone bridge circuit could also be used to increase the sensitivity and accuracy of the pressure sensing system.
  • four strain gauges are attached to the surface of diaphragm 92 , rather than only two strain gauges as shown in FIG. 9 .
  • the output signals from differential amplifiers 102 , 104 are applied to a microcontroller 106 .
  • Microcontroller 106 is integrated into a circuit board 110 within housing 94 .
  • a temperature sensor 112 measures the temperature within the implanted port and inputs a temperature signal to microcontroller 106 .
  • Microcontroller 106 uses the temperature signal from sensor 112 to compensate for variations in body temperature and residual temperature errors not accounted for by strain gauge 98 . Compensating the pressure measurement signal for variations in body temperature increases the accuracy of the pressure sensing system.
  • a TET/telemetry coil 114 is located within housing 94 . Coil 114 is connected to a capacitor 116 to form a tuned tank circuit for receiving power from external portion 36 , and transmitting the pressure measurement to pressure reading device 60 .
  • FIG. 11 is a side, sectional view similar to FIG. 9 , showing a second embodiment 118 for the pressure sensing system of the present invention.
  • a MEMS sensor 120 is provided within housing 94 to measure the mechanical deformation of diaphragm 92 and produce an electrical signal proportional to the pressure within adjustable band 38 .
  • a sealed, silicone oil chamber 122 is provided between diaphragm 92 and MEMS sensor 120 . Oil chamber 122 protects MEMS sensor 120 and transfers the mechanical displacements of diaphragm 92 to the sensor.
  • MEMS sensor 120 outputs an electrical signal to microcontroller 106 indicative of the fluid pressure in reservoir 80 .
  • Microcontroller 106 inputs the signal from the MEMS sensor 120 and a temperature signal from temperature sensor 112 , and calculates the pressure measurement. The pressure measurement is transmitted to pressure reading device 60 in external portion 36 using telemetry signals, as will be described in more detail below.
  • FIG. 12 is a block diagram of a pressure measurement system for first and second embodiments 88 , 118 of the invention.
  • an external control module 126 of the system includes a primary TET coil 130 for transmitting a power signal to the internal control module, indicated generally as 132 .
  • Primary TET coil 130 is located in pressure reading device 60 shown in FIG. 1 .
  • a TET drive circuit 134 controls the application of a power signal to primary TET coil 130 .
  • TET drive circuit 134 is controlled by a microprocessor 136 having an associated memory 138 .
  • a graphical user interface 140 is connected to microprocessor 136 for controlling the data shown on display 66 .
  • External control module 126 also includes a primary telemetry transceiver 142 for transmitting interrogation commands to and receiving response data, including fluid pressure readings, from implant control module 132 .
  • Primary transceiver 142 is electrically connected to microprocessor 136 for inputting and receiving command and data signals.
  • Primary transceiver 142 resonates at a selected RF communication frequency to generate a downlink alternating magnetic field 146 that transmits command data to implant control module 132 .
  • a power supply 150 supplies energy to external control module 126 in order to power system 30 .
  • An ambient pressure sensor 152 is connected to microprocessor 136 .
  • Microprocessor 136 uses the signal from ambient pressure sensor 152 to adjust the pressure reading for variations in atmospheric pressure due to, for example, variations in barometric conditions or altitude, in order to increase the accuracy of the pressure measurement.
  • FIG. 12 also illustrates internal control module 132 implanted beneath the patient's skin 154 .
  • Internal control module 132 is located within housing 94 of injection port 42 .
  • a secondary TET/telemetry coil 156 in internal control module 132 receives power and communication signals from external control module 126 .
  • Coil 156 forms a tuned tank circuit that is inductively coupled with either primary TET coil 130 to power the implant, or primary telemetry coil 144 to receive and transmit data.
  • a telemetry transceiver 158 controls data exchange with coil 156 .
  • internal control module 132 includes a rectifier/power regulator 160 , microcontroller 106 described above, a memory 162 associated with the microcontroller, temperature sensor 112 , pressure sensor 84 and a signal conditioning circuit 164 for amplifying the signal from the pressure sensor.
  • Internal control module 132 transmits the temperature adjusted pressure measurement from pressure sensor 84 to external control module 126 .
  • the received pressure measurement signal is adjusted for changes in ambient pressure and shown on display 66 .
  • FIG. 13 is a side, sectional view showing a third embodiment 170 for measuring fluid pressure in accordance with the invention.
  • internal control module 132 is powered by an internal power supply such as, for example, a battery 172 .
  • Battery 172 replaces primary and secondary TET coils 130 , 156 for powering microcontroller 106 and the other internal components.
  • the pressure sensing system includes a pair of strain gauges 96 , 98 as in first embodiment 88 , for measuring the mechanical deformations of diaphragm 92 corresponding to pressure changes in band 38 . Strain gauges 96 , 98 are incorporated into a balanced, thermally compensated bridge circuit for measuring pressure differentials within the closed fluid circuit of the implant.
  • FIG. 14 is a block diagram of the pressure measurement system of the invention in accordance with the third embodiment 170 shown in FIG. 13 .
  • an internal power supply is used to power internal control module 176 rather than a TET power system as in the first embodiment.
  • the power source for implanted portion 32 is battery 172 rather than the TET primary coil 130 and secondary coil 156 shown in FIG. 12 .
  • secondary, implanted coil 156 is used solely for data communication between the internal and external control modules.
  • a power regulator 174 is provided to control power from battery 172 in order to conserve and extend the life of the battery.
  • FIG. 15 illustrates a fourth embodiment 180 for measuring fluid pressure within adjustable band 38 , in which a passive system is utilized for measuring pressure changes within the working fluid.
  • a variable capacitance 182 is attached to diaphragm 92 in order to measure the mechanical deformations of the diaphragm.
  • Variable capacitance 182 includes a first plate 184 attached near the center of diaphragm 92 on the side opposite fluid reservoir 80 .
  • a second capacitor plate 186 is fixed in position within housing 94 by a capacitor mount 188 .
  • Each of the capacitor plates 184 , 186 is connected to an inductance coil 190 , as shown by lines 192 , to form a resonant circuit.
  • capacitor plate 184 When the fluid pressure within reservoir 80 increases or decreases due to, for instance, changes in the peristaltic pressure against band 38 , the position of capacitor plate 184 varies with the deformation of diaphragm 92 . As fluid pressure increases, diaphragm 92 pushes first capacitor plate 184 closer to second capacitor plate 186 , thereby increasing the capacitance and decreasing the resonant frequency. Likewise, when the hydraulic pressure decreases within the closed implant circuit, first capacitor plate 184 moves with diaphragm 92 in a direction away from second plate 186 , thereby decreasing the capacitance within the resonant circuit and increasing the resonant frequency.
  • FIG. 16 shows a fifth embodiment 196 for measuring fluid pressure in accordance with the present invention.
  • Fifth embodiment 196 is an alternative embodiment for a passive pressure sensing system, in which a variable inductance coil 200 converts the mechanical deformations of diaphragm 92 into a pressure measurement signal.
  • inductance coil 200 is a flat coil spaced beneath diaphragm 92 .
  • a fixed capacitance 202 is connected to inductance coil 200 , as shown by lines 204 , to form an LC resonant circuit 206 .
  • diaphragm 92 deforms up and down in response to pressure variations in the working fluid, the inductance of coil 200 varies.
  • diaphragm 92 deforms in the direction of coil 200 , thereby decreasing the inductance of coil 200 due to eddy current coupling between the metal diaphragm and coil. Conversely, when fluid pressure decreases, diaphragm 92 deforms away from coil 200 , thereby decreasing the eddy current coupling and increasing the inductance of the coil. Accordingly, the inductance of coil 200 is inversely proportional to the pressure of the working fluid. As the inductance of coil 200 changes, the resonant frequency of the LC circuit 206 changes.
  • FIG. 17 is a block diagram of a pressure measurement system for the fourth and fifth embodiments 180 , 196 of the invention.
  • microprocessor 136 controls an inducing coil circuit 208 and inducing coil 210 .
  • Microprocessor 136 varies the frequency of inducing coil 210 to magnetically couple the coil with LC circuit 206 in implanted portion 32 , as indicated by line 212 .
  • the frequency at which the internal and external coils couple will vary with the resonant frequency of the implanted LC circuit 206 .
  • the resonant frequency of the implanted LC circuit will vary with the fluid pressure within band 38 .
  • the variation in resonant frequency is measured by microprocessor 136 through inducing coil circuit 208 . Once detected, the resonant frequency may be compared to known pressures at designated frequencies to determine the fluid pressure within band 38 .
  • a graphical user interface 140 in external module 214 displays the measured fluid pressure on display 66 .
  • FIG. 18 is a graphical representation of a pressure signal 216 from the pressure sensing system of the invention, such as may appear on display 66 during interrogation by a user.
  • the fluid pressure is initially measured by pressure reading device 60 while the patient is stable, resulting in a steady pressure reading as shown.
  • an adjustment is applied to band 38 to decrease the stoma size.
  • the pressure sensing system continues to measure the fluid pressure and transmit the pressure readings through the patient's skin to device 60 .
  • the pressure reading rises slightly following the band adjustment.
  • the patient is then asked to drink a liquid to check the accuracy of the adjustment.
  • the pressure sensing system continues to measure the pressure spikes due to the peristaltic pressure of swallowing the liquid, and transmit the pressure readings to external module 36 for display.
  • the present invention provides the physician with an accurate, real-time visualization of the patient's response to the adjustment.
  • This instantaneous, active display of recorded pressure data enables the physician to perform more accurate band adjustments.
  • the data may be displayed over time to provide a pressure verses time history.
  • the pressure sensing system of the invention may also be used to measure pressure variations in the restriction device at various intervals during treatment. Periodic pressure readings enable the pressure sensing system to function as a diagnostic tool, to ensure that the food intake restriction device is operating effectively.
  • the pressure sensing system may be utilized to detect a no pressure condition within the band, indicating a fluid leakage.
  • the system may be used to detect excessive pressure spikes within the band, indicating a kink in catheter 44 or a blockage within the stoma.
  • the pressure sensing system of the invention also enables a patient to track their own treatment, utilizing an external monitor, such as external device 36 , at home.
  • an external monitor such as external device 36
  • the patient may routinely download pressure readings to their physician's office, thereby reducing the number of office visits required to monitor the patient's treatment.
  • the patient could perform pressure readings at home and notify their physician when the band pressure drops below a specified baseline, indicating the need for an adjustment of the device.
  • the pressure sensing system of the invention thus has benefits as both a diagnostic and a monitoring tool during patient treatment with a bariatric device.

Abstract

A food intake restriction device for forming a restriction in a patient's gastro-intestinal tract and non-invasively communicating pressure data regarding the restriction to an external monitor. The device includes a food intake restriction device implanted substantially about a patient's gastro-intestinal tract to form a restricted opening in the tract. A port is connected to the restriction device. The port contains a working fluid for affecting the size of the restricted opening. A pressure sensing system communicates with the working fluid to measure the pressure of the working fluid. A transmitter communicates the measured fluid pressure to the external monitor.

Description

FIELD OF THE INVENTION
The present invention is related generally to a food intake restriction device for the treatment of morbid obesity and, more particularly, to a non-invasive method of determining the fluid pressure within an adjustable gastric band. In particular, the present invention relates to incorporating a pressure sensor within an adjustable gastric band to measure the pressure of a working fluid within the band, and non-invasively communicating the pressure measurement to an external monitor.
BACKGROUND OF THE INVENTION
Obesity is becoming a growing concern, particularly in the United States, as the number of obese people continues to increase, and more is learned about the negative health effects of obesity. Morbid obesity, in which a person is 100 pounds or more over ideal body weight, in particular poses significant risks for severe health problems. Accordingly, a great deal of attention is being focused on treating obese patients. One method of treating morbid obesity has been to place a restriction device, such as an elongated band, about the upper portion of the stomach. The band is placed so as to form a small gastric pouch above the band and a reduced stoma opening in the stomach. The effect of the band is to reduce the available stomach volume and, thus, the amount of food that can be consumed before becoming “full”. Gastric bands have typically comprised a fluid-filled elastomeric balloon with fixed endpoints that encircles the stomach just inferior to the esophago-gastric junction. When fluid is infused into the balloon, the band expands against the stomach, creating a food intake restriction or stoma in the stomach. To decrease this restriction, fluid is removed from the band.
Food restriction devices have also comprised mechanically adjusted bands that similarly encircle the upper portion of the stomach. These bands include any number of resilient materials or gearing devices, as well as drive members, for adjusting the bands. Additionally, gastric bands have been developed that include both hydraulic and mechanical drive elements. An example of such an adjustable gastric band is disclosed in U.S. Pat. No. 6,067,991, entitled “Mechanical Food Intake Restriction Device” which issued on May 30, 2000, and is incorporated herein by reference. It is also known to restrict the available food volume in the stomach cavity by implanting an inflatable elastomeric balloon within the stomach cavity itself. The balloon is filled with a fluid to expand against the stomach walls and, thereby, decrease the available food volume within the stomach.
With each of the above-described food restriction devices, safe, effective treatment requires that the device be regularly monitored and adjusted to vary the degree of restriction applied to the stomach. With banding devices, the gastric pouch above the band will substantially increase in size following the initial implantation. Accordingly, the stoma opening in the stomach must initially be made large enough to enable the patient to receive adequate nutrition while the stomach adapts to the banding device. As the gastric pouch increases in size, the band may be adjusted to vary the stoma size. In addition, it is desirable to vary the stoma size in order to accommodate changes in the patient's body or treatment regime, or in a more urgent case, to relieve an obstruction or severe esophageal dilatation. Traditionally, adjusting a hydraulic gastric band required a scheduled clinician visit during which a hypodermic needle and syringe were used to permeate the patient's skin and add or remove fluid from the balloon. More recently, implantable pumps have been developed which enable non-invasive adjustments of the band. An external programmer communicates with the implanted pump using telemetry to control the pump. During a scheduled visit, a physician places a hand-held portion of the programmer near the gastric implant and transmits power and command signals to the implant. The implant in turn adjusts the fluid levels in the band and transmits a response command to the programmer.
During these gastric band adjustments, it has been difficult to determine how the adjustment is proceeding, and whether the adjustment will have the intended effect. In an attempt to determine the efficacy of an adjustment, some physicians have utilized fluoroscopy with a Barium swallow as the adjustment is being performed. However, fluoroscopy is both expensive and undesirable due to the radiation doses incurred by both the physician and patient. Other physicians have instructed the patient to drink a glass of water during or after the adjustment to determine whether the water can pass through the adjusted stoma. This method, however, only assures that the patient is not obstructing, and does not provide any information about the efficacy of the adjustment. Oftentimes, a physician may simply adopt a “try as you go” method based upon their prior experience, and the results of an adjustment may not be discovered until hours or days later, when the patient experiences a complete obstruction of the stomach cavity, or the band induces erosion of the stomach tissue.
Accordingly, it is desirable to provide an effective method for evaluating an adjustment of a food intake restriction device during or immediately after an adjustment. In particular, it is desirable to provide a gastric restriction device that includes a pressure measuring system for measuring the pressure within the restriction device and, accordingly, the stoma size. In addition, it is desirable to provide a non-invasive method for measuring fluid pressure during an adjustment and communicating the pressure measurement to an external monitor.
SUMMARY OF THE INVENTION
The present invention provides a method for non-invasively measuring the pressure of a fluid inside an implanted food intake restriction device. The method includes implanting a food intake restriction device in the gastro-intestinal tract of a patient and using a working fluid in the restriction device to form a restricted opening in the gastro-intestinal tract. The pressure in the restricted opening is determined by measuring the pressure of the working fluid with a pressure sensor in communication with the working fluid. An external monitor is placed adjacent to the pressure sensor. A measured pressure signal is transmitted from the pressure sensor to the external monitor and displayed on an external display.
In another embodiment, the present invention provides a food intake restriction system for forming a restriction in a patient's gastro-intestinal tract and non-invasively communicating pressure data regarding the restriction to an external monitor. The system includes a food intake restriction device implanted to form a restriction in the patient's gastro-intestinal tract. A port is connected to the restriction device. The port contains a working fluid for affecting the size of the restricted opening. A pressure sensing system communicates with the working fluid to measure the pressure of the working fluid. A transmitter communicates the measured fluid pressure to the external monitor.
In yet another embodiment, the present invention provides an implanted bariatric treatment device for forming a food intake restriction in a patient's stomach and communicating the pressure of the restriction to an external monitor. The device includes a restriction member implanted in contact with the patient's stomach. The restriction member has a variable fluid volume to create a food intake restriction in the stomach. A control is operatively connected to the restriction member to vary the volume of the restriction member. A pressure sensing system measures the fluid pressure within the restriction member, and non-invasively communicates the measured pressure to the external monitor. The fluid pressure measurement is proportional to the degree of restriction formed in the stomach.
BRIEF DESCRIPTION OF THE FIGURES
FIG. 1 is a schematic illustration of a food intake restriction device of the present invention;
FIG. 2 is a more detailed perspective view of an exemplary implantable portion for the food intake restriction device of FIG. 1;
FIG. 3 is a perspective view of the adjustable gastric band of FIG. 2, showing the band positioned around the gastro-esophageal junction of a patient;
FIG. 4 is a sectional view of the adjustable gastric band of FIG. 2, shown in a deflated configuration;
FIG. 5 is a sectional view of the adjustable gastric band of FIG. 2, shown in an inflated configuration to create a food intake restriction;
FIG. 6 is a side, partially sectioned view of the injection port shown in FIG. 2;
FIG. 7 is an isometric view of the retaining cover shown in FIG. 6;
FIG. 8 is an isometric view of the pressure sensor shown in FIG. 6;
FIG. 9 is a side sectional view illustrating a first embodiment for the pressure sensing system of the present invention;
FIG. 10 is a simplified schematic of the variable resistance circuit of the first embodiment;
FIG. 11 is a side, sectional view of a second embodiment for the pressure sensing system of the invention;
FIG. 12 is a block diagram representing a pressure measurement system associated with the first and second embodiments of the invention;
FIG. 13 is a side, sectional view of a third embodiment for the pressure sensing system of the invention;
FIG. 14 is a block diagram representing a pressure measurement system associated with the third embodiment of the invention;
FIG. 15 is a side, sectional view of a fourth embodiment for the pressure sensing system of the invention;
FIG. 16 is a side, sectional view of a fifth embodiment of the pressure sensing system of the invention;
FIG. 17 is a block diagram of a pressure measurement system associated with the fourth and fifth embodiments of the invention; and
FIG. 18 is a graph indicating a pressure signal from the pressure sensing system, such as may appear on the external monitor display during interrogation by a user.
DETAILED DESCRIPTION OF THE INVENTION
Referring now to the drawings in detail, wherein like numerals indicate the same elements throughout the views, FIG. 1 illustrates a food intake restriction system 30. System 30 comprises a first portion, identified generally as 32, implanted inside of a patient 34, and a second portion, identified generally as 36, located external to the patient. Implanted portion 32 comprises an adjustable gastric band 38 positioned on the upper portion of the patient's stomach 40. Adjustable band 38 may include a cavity made of silicone rubber, or another type of biocompatible material, that inflates inwardly against stomach 40 when filled with a fluid. Alternatively, band 38 may comprise a mechanically adjustable device having a fluid cavity that experiences pressure changes with band adjustments, or a combination hydraulic/mechanical adjustable band. An injection port 42, which will be described in greater detail below, is implanted in a body region accessible for needle injections and/or telemetry communication signals. In the embodiment shown, injection port 42 fluidly communicates with adjustable band 38 via a catheter 44. A surgeon may position and permanently implant injection port 42 inside the body of the patient in order to perform adjustments of the food intake restriction or stoma. Those skilled in the art will recognize that the surgical methods for placing gastric band systems such as implantable portion 32 have evolved greatly during recent years so that the patient may derive optimal therapeutic effect with minimal complications. The surgeon, for example, typically implants injection port 42 in the lateral, subcostal region of the patient's abdomen under the skin and layers of fatty tissue. The surgeon may also implant injection port 42 on the sternum of the patient.
FIG. 2 illustrates an exemplary adjustable gastric band in greater detail. In this embodiment, band 38 includes a variable volume cavity 46 that expands or contracts against the outer wall of the stomach to form an adjustable stoma for controllably restricting food intake into the stomach. A physician may decrease the size of the stoma opening by adding fluid to variable volume cavity 46 or, alternatively, may increase the stoma size by withdrawing fluid from the cavity. Fluid may be added or withdrawn by inserting a needle into injection port 42. Alternatively, fluid may be transferred in a non-invasive manner between band 38 and injection port 42 using telemetry command signals. The fluid may be, but is not restricted to, a 0.9 percent saline solution.
FIG. 3 shows the adjustable gastric band 38 of FIG. 2 applied about the gastro-esophageal junction of a patient. As shown in FIG. 3, band 38 at least substantially encloses the upper portion of stomach 40 near the junction with esophagus 48. FIG. 4 is a sectional view of band 38, showing the band in a deflated configuration. In this view, band 38 contains little to no fluid, thereby maximizing the size of the stoma opening into stomach 40. FIG. 5 is a cross-sectional view of band 38 and stomach 40, similar to FIG. 4, showing band 38 in an inflated, fluid-filled configuration. In this view, the pressure of band 38 against stomach 40 is increased due to the fluid within the band, thereby decreasing the stoma opening to create a food intake restriction. FIG. 5 also schematically illustrates the dilation of esophagus 48 above band 38 to form an upper pouch 50 beneath the diaphragm muscle 52 of the patient.
Returning now to FIG. 1, external portion 36 of food restriction system 30 comprises a pressure-reading device 60 electrically connected (in this embodiment via an electrical cable assembly 62) to a control box 64. Control box 64 includes a display 66, one or more control switches 68, and an external control module, which will be explained in further detail below. Control box 64 may be configured for use, for example, in a physician's office or examination room. Some ways to mount control box 64 include placement upon a desktop, attachment to an examination table, or hanging on a portable stand. Control box 64 may also be configured for carrying in the physician's lab coat pocket, holding by hand, or placing upon the examination table or the reclining patient. Electrical cable assembly 62 may be detachably connected to control box 64 or pressure-reading device 60 to facilitate cleaning, maintenance, usage, and storage of external portion 36 of system 30. Pressure-reading device 60 non-invasively measures the pressure of the fluid within implanted portion 32 even when injection port 42 is implanted beneath thick (at least over 10 centimeters) subcutaneous fat tissue. The physician may hold pressure-reading device 60 against the patient's skin near the location of injection port 42 in the patient and observe the pressure reading on display 66 of control box 64. Pressure-reading device 60 may also be removably attached to the patient, such as during a prolonged examination, using straps, adhesives, and other well-known methods. Pressure-reading device 60 operates through conventional cloth or paper surgical drapes, and may also include a disposal cover (not shown) that may be replaced for each patient.
Turning now to FIG. 6, which depicts a side, partially sectioned view of injection port 42 containing a pressure sensing system for non-invasively measuring the fluid pressure within implanted portion 32. As shown in FIG. 6, injection port 42 comprises a rigid housing 70 having an annular flange 72 containing a plurality of attachment holes 74 for fastening the injection port to tissue in a patient. A surgeon may attach injection port 42 to the tissue, such as the fascia covering an abdominal muscle, using any one of numerous surgical fasteners including suture filaments, staples, and clips. Injection port 42 further comprises a septum 76 typically made of a silicone rubber and compressively retained in housing 70. Septum 76 is penetrable by a Huber needle, or a similar type of injection instrument, for adding or withdrawing fluid from the port. Septum 76 self-seals upon withdrawal of the syringe needle to maintain the volume of fluid inside of injection port 42. Injection port 42 further comprises a reservoir 80 for retaining a working fluid and a catheter connector 82. Connector 82 attaches to catheter 44, shown in FIG. 2, to form a closed hydraulic circuit between reservoir 80 inside of injection port 42 and cavity 46 within adjustable band 38. Fluid from reservoir 80 may be used to expand the volume of band cavity 46. Alternatively, fluid may be removed from cavity 46 and retained in reservoir 80 in order to temporarily decrease the volume of cavity 46. Housing 70 and connector 82 may be integrally molded from a biocompatible polymer or constructed from a metal such as titanium or stainless steel.
A pressure sensing system is provided in injection port 42 to measure the fluid pressure within the closed hydraulic circuit of implanted portion 32. The pressure within the circuit corresponds to the amount of restriction applied by adjustable band 38 to the patient's stomach. Accordingly, measuring the fluid pressure enables a physician to evaluate the restriction created by a band adjustment. Fluid pressure may be measured before, during and/or after an adjustment to verify that the band is properly adjusted. In the embodiment shown in FIG. 6, the pressure sensing system comprises a sensor 84 positioned at the bottom of fluid reservoir 80 within housing 70. A retaining cover 86 extends above pressure sensor 84 to substantially separate the sensor surface from reservoir 80, and protect the sensor from needle penetration. Retaining cover 86 may be made of a ceramic material such as, for example, alumina, which resists needle penetration yet does not interfere with electronic communications between pressure sensor 84 and pressure-reading device 60. Retaining cover 86 includes a vent 90 that allows fluid inside of reservoir 80 to flow to and impact upon the surface of pressure sensor 84.
FIG. 7 is an isometric view of retaining cover 86 illustrating vent 90 in the bottom surface of the cover. FIG. 8 is an isometric view of the exterior of pressure sensor 84. As shown in FIG. 8, the exterior of pressure sensor 84 includes a strain element having a deformable surface. In the embodiment shown, the strain element is a diaphragm 92. Diaphragm 92 may be formed by thinning out a section of a wall in titanium reservoir 80. Diaphragm 92 may be made of titanium or another similar material, and have a thickness between 0.001″ and 0.002″. While the embodiments show a diaphragm as the strain element, the present invention may also be constructed and practiced using other strain elements to convert fluid pressure to a mechanical displacement. Examples of other suitable strain elements include, but are not limited to, Bourdon tubes and bellows assemblies. Pressure sensor 84 is hermetically sealed within a housing 94 to prevent fluid infiltrating and effecting the operation of the sensor. Housing 94 is sealed to port housing 70 to prevent the loss of fluid from the injection port 42. Diaphragm 92 is hermetically sealed to sensor housing 94 to prevent fluid from passing around the edges of the diaphragm and into the internal components of the sensing system. As fluid flows through vent 90 in reservoir 80, the fluid impacts upon the surface of diaphragm 92. The fluid flow through vent 90 enables diaphragm 92 to respond to fluid pressure changes within the hydraulic circuit and convert the pressure changes into a mechanical displacement.
FIG. 9 is a side sectional view of pressure sensor 84, taken along line A-A of FIG. 8, illustrating a first embodiment 88 for measuring fluid pressure. In the embodiment shown in FIG. 9, the mechanical displacement of diaphragm 92 is converted to an electrical signal by a pair of variable resistance, silicon strain gauges 96, 98. Strain gauges 96, 98 are attached to diaphragm 92 on the side opposite the working fluid in reservoir 80. Strain gauge 96 is attached to a center portion of diaphragm 92 to measure the displacement of the diaphragm. The second, matched strain gauge 98 is attached near the outer edge of diaphragm 92. Strain gauges 96, 98 may be attached to diaphragm 92 by adhesives, or may be diffused into the diaphragm structure. As the fluid pressure within band 38 changes, the surface of diaphragm 92 deforms up or down within the surface of housing 94. This deformation of diaphragm 92 produces a resistance change in the center strain gauge 96.
As shown in FIG. 10, strain gauges 96, 98 form the top two resistance elements of a half-compensated, Wheatstone bridge circuit 100. As strain gauge 96 reacts to the mechanical deformations of diaphragm 92, the changing resistance of the gauge changes the potential across the top portion of the bridge circuit. Strain gauge 98 is matched to strain gauge 96 and athermalizes the Wheatstone bridge circuit. Differential amplifiers 102, 104 are connected to bridge circuit 100 to measure the change in potential within the bridge circuit due to the variable resistance strain gauges. In particular, differential amplifier 102 measures the voltage across the entire bridge circuit, while differential amplifier 104 measures the differential voltage across the strain gauge half of bridge circuit 100. The greater the differential between the strain gauge voltages, for a fixed voltage across the bridge, the greater the pressure difference. If desired, a fully compensated Wheatstone bridge circuit could also be used to increase the sensitivity and accuracy of the pressure sensing system. In a fully compensated bridge circuit, four strain gauges are attached to the surface of diaphragm 92, rather than only two strain gauges as shown in FIG. 9.
The output signals from differential amplifiers 102, 104 are applied to a microcontroller 106. Microcontroller 106 is integrated into a circuit board 110 within housing 94. A temperature sensor 112 measures the temperature within the implanted port and inputs a temperature signal to microcontroller 106. Microcontroller 106 uses the temperature signal from sensor 112 to compensate for variations in body temperature and residual temperature errors not accounted for by strain gauge 98. Compensating the pressure measurement signal for variations in body temperature increases the accuracy of the pressure sensing system. Additionally, a TET/telemetry coil 114 is located within housing 94. Coil 114 is connected to a capacitor 116 to form a tuned tank circuit for receiving power from external portion 36, and transmitting the pressure measurement to pressure reading device 60.
FIG. 11 is a side, sectional view similar to FIG. 9, showing a second embodiment 118 for the pressure sensing system of the present invention. In second embodiment 118, a MEMS sensor 120 is provided within housing 94 to measure the mechanical deformation of diaphragm 92 and produce an electrical signal proportional to the pressure within adjustable band 38. A sealed, silicone oil chamber 122 is provided between diaphragm 92 and MEMS sensor 120. Oil chamber 122 protects MEMS sensor 120 and transfers the mechanical displacements of diaphragm 92 to the sensor. MEMS sensor 120 outputs an electrical signal to microcontroller 106 indicative of the fluid pressure in reservoir 80. Microcontroller 106 inputs the signal from the MEMS sensor 120 and a temperature signal from temperature sensor 112, and calculates the pressure measurement. The pressure measurement is transmitted to pressure reading device 60 in external portion 36 using telemetry signals, as will be described in more detail below.
FIG. 12 is a block diagram of a pressure measurement system for first and second embodiments 88, 118 of the invention. As shown in FIG. 12, an external control module 126 of the system includes a primary TET coil 130 for transmitting a power signal to the internal control module, indicated generally as 132. Primary TET coil 130 is located in pressure reading device 60 shown in FIG. 1. A TET drive circuit 134 controls the application of a power signal to primary TET coil 130. TET drive circuit 134 is controlled by a microprocessor 136 having an associated memory 138. A graphical user interface 140 is connected to microprocessor 136 for controlling the data shown on display 66. External control module 126 also includes a primary telemetry transceiver 142 for transmitting interrogation commands to and receiving response data, including fluid pressure readings, from implant control module 132. Primary transceiver 142 is electrically connected to microprocessor 136 for inputting and receiving command and data signals. Primary transceiver 142 resonates at a selected RF communication frequency to generate a downlink alternating magnetic field 146 that transmits command data to implant control module 132. A power supply 150 supplies energy to external control module 126 in order to power system 30. An ambient pressure sensor 152 is connected to microprocessor 136. Microprocessor 136 uses the signal from ambient pressure sensor 152 to adjust the pressure reading for variations in atmospheric pressure due to, for example, variations in barometric conditions or altitude, in order to increase the accuracy of the pressure measurement.
FIG. 12 also illustrates internal control module 132 implanted beneath the patient's skin 154. Internal control module 132 is located within housing 94 of injection port 42. As shown in FIG. 12, a secondary TET/telemetry coil 156 in internal control module 132 receives power and communication signals from external control module 126. Coil 156 forms a tuned tank circuit that is inductively coupled with either primary TET coil 130 to power the implant, or primary telemetry coil 144 to receive and transmit data. A telemetry transceiver 158 controls data exchange with coil 156. Additionally, internal control module 132 includes a rectifier/power regulator 160, microcontroller 106 described above, a memory 162 associated with the microcontroller, temperature sensor 112, pressure sensor 84 and a signal conditioning circuit 164 for amplifying the signal from the pressure sensor. Internal control module 132 transmits the temperature adjusted pressure measurement from pressure sensor 84 to external control module 126. In external module 126, the received pressure measurement signal is adjusted for changes in ambient pressure and shown on display 66.
FIG. 13 is a side, sectional view showing a third embodiment 170 for measuring fluid pressure in accordance with the invention. In the third embodiment 170, internal control module 132 is powered by an internal power supply such as, for example, a battery 172. Battery 172 replaces primary and secondary TET coils 130, 156 for powering microcontroller 106 and the other internal components. In this embodiment, the pressure sensing system includes a pair of strain gauges 96, 98 as in first embodiment 88, for measuring the mechanical deformations of diaphragm 92 corresponding to pressure changes in band 38. Strain gauges 96, 98 are incorporated into a balanced, thermally compensated bridge circuit for measuring pressure differentials within the closed fluid circuit of the implant.
FIG. 14 is a block diagram of the pressure measurement system of the invention in accordance with the third embodiment 170 shown in FIG. 13. In embodiment 170, an internal power supply is used to power internal control module 176 rather than a TET power system as in the first embodiment. The power source for implanted portion 32 is battery 172 rather than the TET primary coil 130 and secondary coil 156 shown in FIG. 12. In the embodiment shown in FIG. 14, secondary, implanted coil 156 is used solely for data communication between the internal and external control modules. A power regulator 174 is provided to control power from battery 172 in order to conserve and extend the life of the battery.
FIG. 15 illustrates a fourth embodiment 180 for measuring fluid pressure within adjustable band 38, in which a passive system is utilized for measuring pressure changes within the working fluid. In this fourth embodiment 180, a variable capacitance 182 is attached to diaphragm 92 in order to measure the mechanical deformations of the diaphragm. Variable capacitance 182 includes a first plate 184 attached near the center of diaphragm 92 on the side opposite fluid reservoir 80. A second capacitor plate 186 is fixed in position within housing 94 by a capacitor mount 188. Each of the capacitor plates 184, 186 is connected to an inductance coil 190, as shown by lines 192, to form a resonant circuit. When the fluid pressure within reservoir 80 increases or decreases due to, for instance, changes in the peristaltic pressure against band 38, the position of capacitor plate 184 varies with the deformation of diaphragm 92. As fluid pressure increases, diaphragm 92 pushes first capacitor plate 184 closer to second capacitor plate 186, thereby increasing the capacitance and decreasing the resonant frequency. Likewise, when the hydraulic pressure decreases within the closed implant circuit, first capacitor plate 184 moves with diaphragm 92 in a direction away from second plate 186, thereby decreasing the capacitance within the resonant circuit and increasing the resonant frequency.
FIG. 16 shows a fifth embodiment 196 for measuring fluid pressure in accordance with the present invention. Fifth embodiment 196 is an alternative embodiment for a passive pressure sensing system, in which a variable inductance coil 200 converts the mechanical deformations of diaphragm 92 into a pressure measurement signal. As shown in FIG. 16, inductance coil 200 is a flat coil spaced beneath diaphragm 92. A fixed capacitance 202 is connected to inductance coil 200, as shown by lines 204, to form an LC resonant circuit 206. As diaphragm 92 deforms up and down in response to pressure variations in the working fluid, the inductance of coil 200 varies. As the fluid pressure increases, diaphragm 92 deforms in the direction of coil 200, thereby decreasing the inductance of coil 200 due to eddy current coupling between the metal diaphragm and coil. Conversely, when fluid pressure decreases, diaphragm 92 deforms away from coil 200, thereby decreasing the eddy current coupling and increasing the inductance of the coil. Accordingly, the inductance of coil 200 is inversely proportional to the pressure of the working fluid. As the inductance of coil 200 changes, the resonant frequency of the LC circuit 206 changes.
FIG. 17 is a block diagram of a pressure measurement system for the fourth and fifth embodiments 180, 196 of the invention. In this system, microprocessor 136 controls an inducing coil circuit 208 and inducing coil 210. Microprocessor 136 varies the frequency of inducing coil 210 to magnetically couple the coil with LC circuit 206 in implanted portion 32, as indicated by line 212. The frequency at which the internal and external coils couple will vary with the resonant frequency of the implanted LC circuit 206. The resonant frequency of the implanted LC circuit will vary with the fluid pressure within band 38. The variation in resonant frequency is measured by microprocessor 136 through inducing coil circuit 208. Once detected, the resonant frequency may be compared to known pressures at designated frequencies to determine the fluid pressure within band 38. A graphical user interface 140 in external module 214 displays the measured fluid pressure on display 66.
FIG. 18 is a graphical representation of a pressure signal 216 from the pressure sensing system of the invention, such as may appear on display 66 during interrogation by a user. In the example shown in FIG. 18, the fluid pressure is initially measured by pressure reading device 60 while the patient is stable, resulting in a steady pressure reading as shown. Next, an adjustment is applied to band 38 to decrease the stoma size. During the band adjustment, the pressure sensing system continues to measure the fluid pressure and transmit the pressure readings through the patient's skin to device 60. As seen in the graph of FIG. 18, the pressure reading rises slightly following the band adjustment. In the example shown, the patient is then asked to drink a liquid to check the accuracy of the adjustment. As the patient drinks, the pressure sensing system continues to measure the pressure spikes due to the peristaltic pressure of swallowing the liquid, and transmit the pressure readings to external module 36 for display. By measuring and visually depicting the loading of the restriction device against the peristaltic motion of the stomach both during and after an adjustment, the present invention provides the physician with an accurate, real-time visualization of the patient's response to the adjustment. This instantaneous, active display of recorded pressure data enables the physician to perform more accurate band adjustments. The data may be displayed over time to provide a pressure verses time history.
In addition to use during adjustments, the pressure sensing system of the invention may also be used to measure pressure variations in the restriction device at various intervals during treatment. Periodic pressure readings enable the pressure sensing system to function as a diagnostic tool, to ensure that the food intake restriction device is operating effectively. In particular, the pressure sensing system may be utilized to detect a no pressure condition within the band, indicating a fluid leakage. Alternatively, the system may be used to detect excessive pressure spikes within the band, indicating a kink in catheter 44 or a blockage within the stoma.
The pressure sensing system of the invention also enables a patient to track their own treatment, utilizing an external monitor, such as external device 36, at home. Using the external device, the patient may routinely download pressure readings to their physician's office, thereby reducing the number of office visits required to monitor the patient's treatment. Additionally, the patient could perform pressure readings at home and notify their physician when the band pressure drops below a specified baseline, indicating the need for an adjustment of the device. The pressure sensing system of the invention thus has benefits as both a diagnostic and a monitoring tool during patient treatment with a bariatric device.
While the present invention has been illustrated by description of several embodiments, it is not the intention of the applicant to restrict or limit the spirit and scope of the appended claims to such detail. Numerous other variations, changes, and substitutions will occur to those skilled in the art without departing from the scope of the invention. For instance, the device and method of the present invention has been illustrated in relation to providing the pressure sensor within the injection port. Alternatively, the sensor could be positioned within a fluid filled portion of the band in order to measure pressure changes within the band. Additionally, the pressure sensor could be associated with an elastomeric balloon implanted within the stomach cavity to measure fluid pressure within the balloon. The structure of each element associated with the present invention can be alternatively described as a means for providing the function performed by the element. It will be understood that the foregoing description is provided by way of example, and that other modifications may occur to those skilled in the art without departing from the scope and spirit of the appended Claims.

Claims (10)

1. A food intake restriction system for forming a restriction in a patient's gastro-intestinal tract and non-invasively communicating pressure data regarding the restriction to an external monitor, the system comprising:
a food intake restriction device adapted to be implanted to form a restriction in a patient's gastro-intestinal tract;
an implanted port connected to the restriction device, said implanted port comprising a self-sealing septum which is penetrable by an external needle and will seal upon withdraw of said needle, the port and the restriction device containing a working fluid for affecting the size of the restriction in the gastro-intestinal tract; and
a pressure sensing system in communication with the working fluid and disposed within the implanted port for making periodic measurements the pressure of the working fluid in the implanted port and restriction device at various intervals and transmitting pressure measurement data to the external monitor.
2. The food intake restriction system of claim 1, wherein the pressure of the working fluid is proportional to the degree of restriction formed in the gastro-intestinal tract.
3. The food intake restriction system of claim 2, wherein the pressure sensing system includes a mechanically deformable surface in contact with the working fluid, and wherein the surface deforms in proportion to the pressure of the working fluid.
4. The food intake restriction system of claim 3, wherein the mechanical deformations of the surface are converted into an electrical signal indicative of the pressure within the working fluid.
5. The food intake restriction system of claim 4, wherein the pressure sensing system comprises two or more variable resistance elements attached to the deformable surface, the resistance of the elements varying in response to the mechanical deformations of the surface; and wherein the resistance elements are connected in an electrical circuit, the output of the circuit providing a measurement of the working fluid pressure.
6. The food intake restriction system of claim 5, further comprising a tuned tank circuit in the port for non-invasively transmitting the pressure measurement data from the variable resistance circuit to the external monitor.
7. The food intake restriction system of claim 4, wherein the pressure sensing system includes a variable capacitance capacitor, the capacitance of the capacitor varying in response to pressure changes in the working fluid, the variation in the capacitance providing a measurement of the working fluid pressure.
8. The food intake restriction system of claim 4, wherein the working fluid is transferable between the port and the restriction device in a closed fluid circuit to affect the size of the gastro-intestinal restriction.
9. The food intake restriction system of claim 4, wherein the pressure sensing system measures the working fluid pressure and transmits the pressure measurement data to the external monitor during an adjustment of the food intake restriction device.
10. The food intake restriction system of claim 4, wherein the pressure sensing system includes a variable inductance coil adjacent the deformable surface, the inductance of the coil varying in response to pressure changes in the working fluid, the variation in inductance providing a measurement of the working fluid pressure.
US11/065,407 2005-02-24 2005-02-24 Non-invasive measurement of fluid pressure in an adjustable gastric band Expired - Fee Related US7909754B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/065,407 US7909754B2 (en) 2005-02-24 2005-02-24 Non-invasive measurement of fluid pressure in an adjustable gastric band
US13/023,729 US20110130626A1 (en) 2005-02-24 2011-02-09 Non-Invasive Measurement of Fluid Pressure In An Adjustable Gastric Band

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/065,407 US7909754B2 (en) 2005-02-24 2005-02-24 Non-invasive measurement of fluid pressure in an adjustable gastric band

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/023,729 Division US20110130626A1 (en) 2005-02-24 2011-02-09 Non-Invasive Measurement of Fluid Pressure In An Adjustable Gastric Band

Publications (2)

Publication Number Publication Date
US20060189887A1 US20060189887A1 (en) 2006-08-24
US7909754B2 true US7909754B2 (en) 2011-03-22

Family

ID=36913694

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/065,407 Expired - Fee Related US7909754B2 (en) 2005-02-24 2005-02-24 Non-invasive measurement of fluid pressure in an adjustable gastric band
US13/023,729 Abandoned US20110130626A1 (en) 2005-02-24 2011-02-09 Non-Invasive Measurement of Fluid Pressure In An Adjustable Gastric Band

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/023,729 Abandoned US20110130626A1 (en) 2005-02-24 2011-02-09 Non-Invasive Measurement of Fluid Pressure In An Adjustable Gastric Band

Country Status (1)

Country Link
US (2) US7909754B2 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090264901A1 (en) * 2008-04-17 2009-10-22 Ethan Franklin Implantable access port device and attachment system
US20100217198A1 (en) * 2008-04-17 2010-08-26 Allergan, Inc. Implantable access port device having a safety cap
US20110054407A1 (en) * 2009-08-26 2011-03-03 Allergan, Inc. System including access port and applicator tool
US20110196195A1 (en) * 2010-02-05 2011-08-11 Allergan, Inc. Implantable subcutaneous access port
US20110196394A1 (en) * 2010-02-10 2011-08-11 Allergan, Inc. Implantable injection port
US20110218392A1 (en) * 2009-08-26 2011-09-08 Allergan, Inc. Implantable bottom exit port
US8708979B2 (en) 2009-08-26 2014-04-29 Apollo Endosurgery, Inc. Implantable coupling device
US8801597B2 (en) 2011-08-25 2014-08-12 Apollo Endosurgery, Inc. Implantable access port with mesh attachment rivets
US8821373B2 (en) 2011-05-10 2014-09-02 Apollo Endosurgery, Inc. Directionless (orientation independent) needle injection port
US8858421B2 (en) 2011-11-15 2014-10-14 Apollo Endosurgery, Inc. Interior needle stick guard stems for tubes
US8882655B2 (en) 2010-09-14 2014-11-11 Apollo Endosurgery, Inc. Implantable access port system
US8905916B2 (en) 2010-08-16 2014-12-09 Apollo Endosurgery, Inc. Implantable access port system
US8992415B2 (en) 2010-04-30 2015-03-31 Apollo Endosurgery, Inc. Implantable device to protect tubing from puncture
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
US9089395B2 (en) 2011-11-16 2015-07-28 Appolo Endosurgery, Inc. Pre-loaded septum for use with an access port
US9125718B2 (en) 2010-04-30 2015-09-08 Apollo Endosurgery, Inc. Electronically enhanced access port for a fluid filled implant
US9192501B2 (en) 2010-04-30 2015-11-24 Apollo Endosurgery, Inc. Remotely powered remotely adjustable gastric band system
US9199069B2 (en) 2011-10-20 2015-12-01 Apollo Endosurgery, Inc. Implantable injection port
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338433B2 (en) 2002-08-13 2008-03-04 Allergan, Inc. Remotely adjustable gastric banding method
DE60331457D1 (en) 2002-08-28 2010-04-08 Allergan Inc TEMPTING MAGNETIC BANDING DEVICE
JP2007527279A (en) 2004-01-23 2007-09-27 アラーガン、インコーポレイテッド One-piece adjustable gastric band that can be fixed removably
ES2333024T3 (en) 2004-03-08 2010-02-16 Allergan Medical S.A. CLOSURE SYSTEM FOR TUBULAR ORGANS.
ATE517652T1 (en) 2004-03-18 2011-08-15 Allergan Inc DEVICE FOR ADJUSTING THE VOLUME OF INTRAGASTRAL BALLOONS
US20060195139A1 (en) * 2004-03-23 2006-08-31 Michael Gertner Extragastric devices and methods for gastroplasty
US7255675B2 (en) * 2004-03-23 2007-08-14 Michael Gertner Devices and methods to treat a patient
US20050228415A1 (en) * 2004-03-23 2005-10-13 Michael Gertner Methods and devices for percutaneous, non-laparoscopic treatment of obesity
US7946976B2 (en) * 2004-03-23 2011-05-24 Michael Gertner Methods and devices for the surgical creation of satiety and biofeedback pathways
WO2006049725A2 (en) * 2004-03-23 2006-05-11 Minimus Surgical Systems Surgical systems and devices to enhance gastric restriction therapies
US7775966B2 (en) 2005-02-24 2010-08-17 Ethicon Endo-Surgery, Inc. Non-invasive pressure measurement in a fluid adjustable restrictive device
US7699770B2 (en) 2005-02-24 2010-04-20 Ethicon Endo-Surgery, Inc. Device for non-invasive measurement of fluid pressure in an adjustable restriction device
US7775215B2 (en) 2005-02-24 2010-08-17 Ethicon Endo-Surgery, Inc. System and method for determining implanted device positioning and obtaining pressure data
US8016744B2 (en) 2005-02-24 2011-09-13 Ethicon Endo-Surgery, Inc. External pressure-based gastric band adjustment system and method
US8066629B2 (en) 2005-02-24 2011-11-29 Ethicon Endo-Surgery, Inc. Apparatus for adjustment and sensing of gastric band pressure
US7658196B2 (en) 2005-02-24 2010-02-09 Ethicon Endo-Surgery, Inc. System and method for determining implanted device orientation
US7927270B2 (en) 2005-02-24 2011-04-19 Ethicon Endo-Surgery, Inc. External mechanical pressure sensor for gastric band pressure measurements
US8251888B2 (en) 2005-04-13 2012-08-28 Mitchell Steven Roslin Artificial gastric valve
US7899540B2 (en) * 2005-04-29 2011-03-01 Cyberonics, Inc. Noninvasively adjustable gastric band
US7835796B2 (en) * 2005-04-29 2010-11-16 Cyberonics, Inc. Weight loss method and device
US7798954B2 (en) 2006-01-04 2010-09-21 Allergan, Inc. Hydraulic gastric band with collapsible reservoir
US8043206B2 (en) 2006-01-04 2011-10-25 Allergan, Inc. Self-regulating gastric band with pressure data processing
US8870742B2 (en) 2006-04-06 2014-10-28 Ethicon Endo-Surgery, Inc. GUI for an implantable restriction device and a data logger
US20080250341A1 (en) * 2006-04-06 2008-10-09 Ethicon Endo-Surgery, Inc. Gui With Trend Analysis for an Implantable Restriction Device and a Data Logger
US8152710B2 (en) 2006-04-06 2012-04-10 Ethicon Endo-Surgery, Inc. Physiological parameter analysis for an implantable restriction device and a data logger
MX2009002948A (en) 2006-09-19 2009-03-31 Kci Licensing Inc Reduced pressure treatment system having blockage clearing and dual-zone pressure protection capabilities.
AU2016203841B2 (en) * 2006-09-19 2018-02-22 Solventum Intellectual Properties Company Reduced pressure treatment system having blockage clearing and dual-zone pressure protection capabilities
AU2013205545B2 (en) * 2006-09-19 2016-03-17 Solventum Intellectual Properties Company Reduced pressure treatment system having blockage clearing and dual-zone pressure protection capabilities
US8366690B2 (en) 2006-09-19 2013-02-05 Kci Licensing, Inc. System and method for determining a fill status of a canister of fluid in a reduced pressure treatment system
US8061360B2 (en) 2006-09-19 2011-11-22 Kci Licensing, Inc. System and method for locating fluid leaks at a drape of a reduced pressure delivery system
US20080097249A1 (en) * 2006-10-20 2008-04-24 Ellipse Technologies, Inc. External sensing system for gastric restriction devices
RU2428208C2 (en) 2007-02-09 2011-09-10 КейСиАй Лайсензинг Инк. System and method of low pressure control in tissue area
CA2675263C (en) 2007-02-20 2012-01-03 Kci Licensing, Inc. System and method for distinguishing leaks from a disengaged canister condition in a reduced pressure treatment system
US8187163B2 (en) 2007-12-10 2012-05-29 Ethicon Endo-Surgery, Inc. Methods for implanting a gastric restriction device
US8100870B2 (en) 2007-12-14 2012-01-24 Ethicon Endo-Surgery, Inc. Adjustable height gastric restriction devices and methods
US8377079B2 (en) 2007-12-27 2013-02-19 Ethicon Endo-Surgery, Inc. Constant force mechanisms for regulating restriction devices
US8142452B2 (en) 2007-12-27 2012-03-27 Ethicon Endo-Surgery, Inc. Controlling pressure in adjustable restriction devices
US8591395B2 (en) 2008-01-28 2013-11-26 Ethicon Endo-Surgery, Inc. Gastric restriction device data handling devices and methods
US8337389B2 (en) * 2008-01-28 2012-12-25 Ethicon Endo-Surgery, Inc. Methods and devices for diagnosing performance of a gastric restriction system
US8192350B2 (en) 2008-01-28 2012-06-05 Ethicon Endo-Surgery, Inc. Methods and devices for measuring impedance in a gastric restriction system
EP2240138B1 (en) * 2008-01-29 2021-07-21 Implantica Patent Ltd. Apparatus for treating obesity
US8221439B2 (en) 2008-02-07 2012-07-17 Ethicon Endo-Surgery, Inc. Powering implantable restriction systems using kinetic motion
US7844342B2 (en) 2008-02-07 2010-11-30 Ethicon Endo-Surgery, Inc. Powering implantable restriction systems using light
US8114345B2 (en) 2008-02-08 2012-02-14 Ethicon Endo-Surgery, Inc. System and method of sterilizing an implantable medical device
US8057492B2 (en) * 2008-02-12 2011-11-15 Ethicon Endo-Surgery, Inc. Automatically adjusting band system with MEMS pump
US8591532B2 (en) * 2008-02-12 2013-11-26 Ethicon Endo-Sugery, Inc. Automatically adjusting band system
US8034065B2 (en) 2008-02-26 2011-10-11 Ethicon Endo-Surgery, Inc. Controlling pressure in adjustable restriction devices
US8187162B2 (en) 2008-03-06 2012-05-29 Ethicon Endo-Surgery, Inc. Reorientation port
US8233995B2 (en) 2008-03-06 2012-07-31 Ethicon Endo-Surgery, Inc. System and method of aligning an implantable antenna
US8292800B2 (en) 2008-06-11 2012-10-23 Allergan, Inc. Implantable pump system
CA2937100C (en) 2008-08-08 2019-07-02 Kci Licensing, Inc. Reduced-pressure treatment systems with reservoir control
EP2362762A1 (en) 2008-10-06 2011-09-07 Allergan Medical Sàrl Mechanical gastric band with cushions
US20100185049A1 (en) 2008-10-22 2010-07-22 Allergan, Inc. Dome and screw valves for remotely adjustable gastric banding systems
US20100191265A1 (en) * 2009-01-29 2010-07-29 Cavu Medical, Inc. Assembly and method for automatically controlling pressure for a gastric band
US20100191271A1 (en) * 2009-01-29 2010-07-29 Lilip Lau Assembly and method for automatically controlling pressure for a gastric band
US8678993B2 (en) 2010-02-12 2014-03-25 Apollo Endosurgery, Inc. Remotely adjustable gastric banding system
US8758221B2 (en) 2010-02-24 2014-06-24 Apollo Endosurgery, Inc. Source reservoir with potential energy for remotely adjustable gastric banding system
US8840541B2 (en) 2010-02-25 2014-09-23 Apollo Endosurgery, Inc. Pressure sensing gastric banding system
US8764624B2 (en) 2010-02-25 2014-07-01 Apollo Endosurgery, Inc. Inductively powered remotely adjustable gastric banding system
US9265422B2 (en) 2010-04-27 2016-02-23 Apollo Endosurgery, Inc. System and method for determining an adjustment to a gastric band based on satiety state data and weight loss data
US8939888B2 (en) 2010-04-28 2015-01-27 Apollo Endosurgery, Inc. Method and system for determining the pressure of a fluid in a syringe, an access port, a catheter, and a gastric band
US9028394B2 (en) 2010-04-29 2015-05-12 Apollo Endosurgery, Inc. Self-adjusting mechanical gastric band
US20110270024A1 (en) 2010-04-29 2011-11-03 Allergan, Inc. Self-adjusting gastric band having various compliant components
US9044298B2 (en) 2010-04-29 2015-06-02 Apollo Endosurgery, Inc. Self-adjusting gastric band
US9226840B2 (en) 2010-06-03 2016-01-05 Apollo Endosurgery, Inc. Magnetically coupled implantable pump system and method
US8517915B2 (en) 2010-06-10 2013-08-27 Allergan, Inc. Remotely adjustable gastric banding system
US8698373B2 (en) 2010-08-18 2014-04-15 Apollo Endosurgery, Inc. Pare piezo power with energy recovery
US9211207B2 (en) 2010-08-18 2015-12-15 Apollo Endosurgery, Inc. Power regulated implant
US20120059216A1 (en) 2010-09-07 2012-03-08 Allergan, Inc. Remotely adjustable gastric banding system
US8961393B2 (en) 2010-11-15 2015-02-24 Apollo Endosurgery, Inc. Gastric band devices and drive systems
US20120130273A1 (en) * 2010-11-22 2012-05-24 Hassler Jr William L Non-Invasive Measurement Of Fluid Pressure In An Adjustable Gastric Band
US8725435B2 (en) 2011-04-13 2014-05-13 Apollo Endosurgery, Inc. Syringe-based leak detection system
US8876694B2 (en) 2011-12-07 2014-11-04 Apollo Endosurgery, Inc. Tube connector with a guiding tip
US8961394B2 (en) 2011-12-20 2015-02-24 Apollo Endosurgery, Inc. Self-sealing fluid joint for use with a gastric band
US10098551B2 (en) * 2013-01-31 2018-10-16 Pacesetter, Inc. Wireless MEMS left atrial pressure sensor
CN107529985B (en) 2015-03-31 2020-03-31 加州理工学院 Biocompatible encapsulation for long-term implantable sensors and electronics
RU2699281C1 (en) * 2015-12-21 2019-09-04 Конинклейке Филипс Н.В. Method and device for controlling food and/or drink intake by an individual
EP3621512B1 (en) * 2017-05-12 2024-02-28 California Institute of Technology Implantable extracompartmental pressure sensor
US11701504B2 (en) 2020-01-17 2023-07-18 California Institute Of Technology Implantable intracranial pressure sensor

Citations (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3939823A (en) 1975-01-28 1976-02-24 The United States Of America As Represented By The Department Of Health, Education And Welfare Esophageal transducer
US3942535A (en) 1973-09-27 1976-03-09 G. D. Searle & Co. Rechargeable tissue stimulating system
US4407296A (en) 1980-09-12 1983-10-04 Medtronic, Inc. Integral hermetic impantable pressure transducer
US4471635A (en) 1981-11-04 1984-09-18 Karl Mayer Textilmaschinenfabrik, Gmbh Slider needles for warp knitting machines
US4571749A (en) 1982-09-21 1986-02-25 The Johns Hopkins University Manually actuated hydraulic sphincter
US4738267A (en) * 1985-03-22 1988-04-19 Universite Paul Sabatier (Toulouse Iii) Implantable, intracranial-pressure sensor
US5314457A (en) 1993-04-08 1994-05-24 Jeutter Dean C Regenerative electrical
US5522865A (en) 1989-09-22 1996-06-04 Alfred E. Mann Foundation For Scientific Research Voltage/current control system for a human tissue stimulator
US5531774A (en) 1989-09-22 1996-07-02 Alfred E. Mann Foundation For Scientific Research Multichannel implantable cochlear stimulator having programmable bipolar, monopolar or multipolar electrode configurations
US5540731A (en) 1994-09-21 1996-07-30 Medtronic, Inc. Method and apparatus for pressure detecting and treating obstructive airway disorders
US5562714A (en) 1995-02-03 1996-10-08 Medtronic, Inc. Magnetic field strength regulator for implant
US5603726A (en) 1989-09-22 1997-02-18 Alfred E. Mann Foundation For Scientific Research Multichannel cochlear implant system including wearable speech processor
US5713939A (en) 1996-09-16 1998-02-03 Sulzer Intermedics Inc. Data communication system for control of transcutaneous energy transmission to an implantable medical device
US5733313A (en) 1996-08-01 1998-03-31 Exonix Corporation RF coupled, implantable medical device with rechargeable back-up power source
US5755748A (en) 1996-07-24 1998-05-26 Dew Engineering & Development Limited Transcutaneous energy transfer device
US5807397A (en) 1995-01-04 1998-09-15 Plexus, Inc. Implantable stimulator with replenishable, high value capacitive power source and method therefor
US5876245A (en) 1995-04-07 1999-03-02 Hirose Electric Co., Ltd. Circuit board electrical connector
EP0930086A1 (en) 1998-01-15 1999-07-21 Dew Engineering and Development Limited Transcutaneous energy transfer device
US5938669A (en) 1997-05-07 1999-08-17 Klasamed S.A. Adjustable gastric banding device for contracting a patient's stomach
US5938691A (en) 1989-09-22 1999-08-17 Alfred E. Mann Foundation Multichannel implantable cochlear stimulator
US5995874A (en) 1998-02-09 1999-11-30 Dew Engineering And Development Limited Transcutaneous energy transfer device
US6058330A (en) 1998-03-06 2000-05-02 Dew Engineering And Development Limited Transcutaneous energy transfer device
US6067991A (en) 1998-08-13 2000-05-30 Forsell; Peter Mechanical food intake restriction device
US6099495A (en) 1998-04-30 2000-08-08 Medtronic, Inc. Implantable electrical transducer powered from capacitive storage energy source
US6210347B1 (en) 1998-08-13 2001-04-03 Peter Forsell Remote control food intake restriction device
US6285897B1 (en) 1999-04-07 2001-09-04 Endonetics, Inc. Remote physiological monitoring system
US6442434B1 (en) 1999-10-19 2002-08-27 Abiomed, Inc. Methods and apparatus for providing a sufficiently stable power to a load in an energy transfer system
US6450946B1 (en) 2000-02-11 2002-09-17 Obtech Medical Ag Food intake restriction with wireless energy transfer
US6450173B1 (en) * 1999-08-12 2002-09-17 Obtech Medical Ag Heartburn and reflux disease treatment with controlled wireless energy supply
US6454699B1 (en) 2000-02-11 2002-09-24 Obtech Medical Ag Food intake restriction with controlled wireless energy supply
US6454700B1 (en) 2000-02-09 2002-09-24 Obtech Medical Ag Heartburn and reflux disease treatment apparatus with wireless energy supply
US6453907B1 (en) 1999-08-12 2002-09-24 Obtech Medical Ag Food intake restriction with energy transfer device
US6460543B1 (en) 1998-08-13 2002-10-08 Obtech Medical Ag Non-injection port food intake restriction device
US6463935B1 (en) 2000-02-10 2002-10-15 Obtech Medical Ag Controlled heartburn and reflux disease treatment
US6464628B1 (en) 1999-08-12 2002-10-15 Obtech Medical Ag Mechanical anal incontinence
US6470892B1 (en) 2000-02-10 2002-10-29 Obtech Medical Ag Mechanical heartburn and reflux treatment
US6475136B1 (en) 2000-02-14 2002-11-05 Obtech Medical Ag Hydraulic heartburn and reflux treatment
US6482145B1 (en) 2000-02-14 2002-11-19 Obtech Medical Ag Hydraulic anal incontinence treatment
US20030092962A1 (en) 1999-08-12 2003-05-15 Obtech Medical Ag Anal incontinence disease treatment with controlled wireless energy supply
US20030093117A1 (en) 1999-06-25 2003-05-15 Vahid Saadat Implantable artificial partition and methods of use
US20030176795A1 (en) * 2000-06-02 2003-09-18 Harris Thomas John Blood pressure measurement apparatus and method
US6689046B2 (en) 2000-09-29 2004-02-10 Precision Medical Devices, Inc. Body fluid flow control method and device
WO2004014245A1 (en) 2002-08-13 2004-02-19 Inamed Medical Products Corporation Remotely adjustable gastric banding device and method
US20040082867A1 (en) * 2002-10-29 2004-04-29 Pearl Technology Holdings, Llc Vascular graft with integrated sensor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050187430A1 (en) * 2004-02-19 2005-08-25 Medtronic, Inc. Fluid charging mechanism for balloon catheter system

Patent Citations (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3942535A (en) 1973-09-27 1976-03-09 G. D. Searle & Co. Rechargeable tissue stimulating system
US3939823A (en) 1975-01-28 1976-02-24 The United States Of America As Represented By The Department Of Health, Education And Welfare Esophageal transducer
US4407296A (en) 1980-09-12 1983-10-04 Medtronic, Inc. Integral hermetic impantable pressure transducer
US4471635A (en) 1981-11-04 1984-09-18 Karl Mayer Textilmaschinenfabrik, Gmbh Slider needles for warp knitting machines
US4571749A (en) 1982-09-21 1986-02-25 The Johns Hopkins University Manually actuated hydraulic sphincter
US4738267A (en) * 1985-03-22 1988-04-19 Universite Paul Sabatier (Toulouse Iii) Implantable, intracranial-pressure sensor
US5603726A (en) 1989-09-22 1997-02-18 Alfred E. Mann Foundation For Scientific Research Multichannel cochlear implant system including wearable speech processor
US5522865A (en) 1989-09-22 1996-06-04 Alfred E. Mann Foundation For Scientific Research Voltage/current control system for a human tissue stimulator
US5531774A (en) 1989-09-22 1996-07-02 Alfred E. Mann Foundation For Scientific Research Multichannel implantable cochlear stimulator having programmable bipolar, monopolar or multipolar electrode configurations
US5938691A (en) 1989-09-22 1999-08-17 Alfred E. Mann Foundation Multichannel implantable cochlear stimulator
US5776172A (en) 1989-09-22 1998-07-07 Alfred E. Mann Foundation For Scientific Research Multichannel implantable cochlear stimulator
US5314457A (en) 1993-04-08 1994-05-24 Jeutter Dean C Regenerative electrical
US5540731A (en) 1994-09-21 1996-07-30 Medtronic, Inc. Method and apparatus for pressure detecting and treating obstructive airway disorders
US5807397A (en) 1995-01-04 1998-09-15 Plexus, Inc. Implantable stimulator with replenishable, high value capacitive power source and method therefor
US5562714A (en) 1995-02-03 1996-10-08 Medtronic, Inc. Magnetic field strength regulator for implant
US5876245A (en) 1995-04-07 1999-03-02 Hirose Electric Co., Ltd. Circuit board electrical connector
US5755748A (en) 1996-07-24 1998-05-26 Dew Engineering & Development Limited Transcutaneous energy transfer device
US5733313A (en) 1996-08-01 1998-03-31 Exonix Corporation RF coupled, implantable medical device with rechargeable back-up power source
US5713939A (en) 1996-09-16 1998-02-03 Sulzer Intermedics Inc. Data communication system for control of transcutaneous energy transmission to an implantable medical device
US5938669A (en) 1997-05-07 1999-08-17 Klasamed S.A. Adjustable gastric banding device for contracting a patient's stomach
EP0930086A1 (en) 1998-01-15 1999-07-21 Dew Engineering and Development Limited Transcutaneous energy transfer device
US5995874A (en) 1998-02-09 1999-11-30 Dew Engineering And Development Limited Transcutaneous energy transfer device
US6058330A (en) 1998-03-06 2000-05-02 Dew Engineering And Development Limited Transcutaneous energy transfer device
US6430444B1 (en) 1998-03-06 2002-08-06 Dew Engineering And Development Limited Transcutaneous energy transfer device
US6099495A (en) 1998-04-30 2000-08-08 Medtronic, Inc. Implantable electrical transducer powered from capacitive storage energy source
US6067991A (en) 1998-08-13 2000-05-30 Forsell; Peter Mechanical food intake restriction device
US6460543B1 (en) 1998-08-13 2002-10-08 Obtech Medical Ag Non-injection port food intake restriction device
US6210347B1 (en) 1998-08-13 2001-04-03 Peter Forsell Remote control food intake restriction device
US6285897B1 (en) 1999-04-07 2001-09-04 Endonetics, Inc. Remote physiological monitoring system
US20030093117A1 (en) 1999-06-25 2003-05-15 Vahid Saadat Implantable artificial partition and methods of use
US20030092962A1 (en) 1999-08-12 2003-05-15 Obtech Medical Ag Anal incontinence disease treatment with controlled wireless energy supply
US6464628B1 (en) 1999-08-12 2002-10-15 Obtech Medical Ag Mechanical anal incontinence
US6450173B1 (en) * 1999-08-12 2002-09-17 Obtech Medical Ag Heartburn and reflux disease treatment with controlled wireless energy supply
US6461293B1 (en) 1999-08-12 2002-10-08 Obtech Medical Ag Controlled food intake restriction
US6453907B1 (en) 1999-08-12 2002-09-24 Obtech Medical Ag Food intake restriction with energy transfer device
US20020123779A1 (en) 1999-10-19 2002-09-05 Abiomed, Inc. Methods and apparatus for providing a sufficiently stable power to a load in an energy transfer system
US6442434B1 (en) 1999-10-19 2002-08-27 Abiomed, Inc. Methods and apparatus for providing a sufficiently stable power to a load in an energy transfer system
US20020128690A1 (en) 1999-10-19 2002-09-12 Abiomed, Inc. Methods and apparatus for providing a sufficiently stable power to a load in an energy transfer system
US6454700B1 (en) 2000-02-09 2002-09-24 Obtech Medical Ag Heartburn and reflux disease treatment apparatus with wireless energy supply
US6463935B1 (en) 2000-02-10 2002-10-15 Obtech Medical Ag Controlled heartburn and reflux disease treatment
US6470892B1 (en) 2000-02-10 2002-10-29 Obtech Medical Ag Mechanical heartburn and reflux treatment
US20030032857A1 (en) 2000-02-11 2003-02-13 Obtech Medical Ag Mechanical anal incontinence
US6450946B1 (en) 2000-02-11 2002-09-17 Obtech Medical Ag Food intake restriction with wireless energy transfer
US6454699B1 (en) 2000-02-11 2002-09-24 Obtech Medical Ag Food intake restriction with controlled wireless energy supply
US6475136B1 (en) 2000-02-14 2002-11-05 Obtech Medical Ag Hydraulic heartburn and reflux treatment
US6482145B1 (en) 2000-02-14 2002-11-19 Obtech Medical Ag Hydraulic anal incontinence treatment
US20030176795A1 (en) * 2000-06-02 2003-09-18 Harris Thomas John Blood pressure measurement apparatus and method
US6689046B2 (en) 2000-09-29 2004-02-10 Precision Medical Devices, Inc. Body fluid flow control method and device
WO2004014245A1 (en) 2002-08-13 2004-02-19 Inamed Medical Products Corporation Remotely adjustable gastric banding device and method
US20040082867A1 (en) * 2002-10-29 2004-04-29 Pearl Technology Holdings, Llc Vascular graft with integrated sensor

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090264901A1 (en) * 2008-04-17 2009-10-22 Ethan Franklin Implantable access port device and attachment system
US20100217198A1 (en) * 2008-04-17 2010-08-26 Allergan, Inc. Implantable access port device having a safety cap
US9023062B2 (en) 2008-04-17 2015-05-05 Apollo Endosurgery, Inc. Implantable access port device and attachment system
US8398654B2 (en) 2008-04-17 2013-03-19 Allergan, Inc. Implantable access port device and attachment system
US8409221B2 (en) 2008-04-17 2013-04-02 Allergan, Inc. Implantable access port device having a safety cap
US9023063B2 (en) 2008-04-17 2015-05-05 Apollo Endosurgery, Inc. Implantable access port device having a safety cap
US20110054407A1 (en) * 2009-08-26 2011-03-03 Allergan, Inc. System including access port and applicator tool
US20110218392A1 (en) * 2009-08-26 2011-09-08 Allergan, Inc. Implantable bottom exit port
US8506532B2 (en) 2009-08-26 2013-08-13 Allergan, Inc. System including access port and applicator tool
US8708979B2 (en) 2009-08-26 2014-04-29 Apollo Endosurgery, Inc. Implantable coupling device
US8715158B2 (en) 2009-08-26 2014-05-06 Apollo Endosurgery, Inc. Implantable bottom exit port
US20110196195A1 (en) * 2010-02-05 2011-08-11 Allergan, Inc. Implantable subcutaneous access port
US20110196394A1 (en) * 2010-02-10 2011-08-11 Allergan, Inc. Implantable injection port
US8882728B2 (en) 2010-02-10 2014-11-11 Apollo Endosurgery, Inc. Implantable injection port
US9125718B2 (en) 2010-04-30 2015-09-08 Apollo Endosurgery, Inc. Electronically enhanced access port for a fluid filled implant
US9192501B2 (en) 2010-04-30 2015-11-24 Apollo Endosurgery, Inc. Remotely powered remotely adjustable gastric band system
US8992415B2 (en) 2010-04-30 2015-03-31 Apollo Endosurgery, Inc. Implantable device to protect tubing from puncture
US9241819B2 (en) 2010-04-30 2016-01-26 Apollo Endosurgery, Inc. Implantable device to protect tubing from puncture
US8905916B2 (en) 2010-08-16 2014-12-09 Apollo Endosurgery, Inc. Implantable access port system
US8882655B2 (en) 2010-09-14 2014-11-11 Apollo Endosurgery, Inc. Implantable access port system
US8821373B2 (en) 2011-05-10 2014-09-02 Apollo Endosurgery, Inc. Directionless (orientation independent) needle injection port
US8801597B2 (en) 2011-08-25 2014-08-12 Apollo Endosurgery, Inc. Implantable access port with mesh attachment rivets
US9199069B2 (en) 2011-10-20 2015-12-01 Apollo Endosurgery, Inc. Implantable injection port
US8858421B2 (en) 2011-11-15 2014-10-14 Apollo Endosurgery, Inc. Interior needle stick guard stems for tubes
US9089395B2 (en) 2011-11-16 2015-07-28 Appolo Endosurgery, Inc. Pre-loaded septum for use with an access port
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food

Also Published As

Publication number Publication date
US20060189887A1 (en) 2006-08-24
US20110130626A1 (en) 2011-06-02

Similar Documents

Publication Publication Date Title
US7909754B2 (en) Non-invasive measurement of fluid pressure in an adjustable gastric band
US7699770B2 (en) Device for non-invasive measurement of fluid pressure in an adjustable restriction device
EP1832253B1 (en) Non-invasive pressure measurement in a fluid adjustable restrictive device
EP1832254B1 (en) System for determining implanted device positioning and obtaining pressure data
EP2103285B1 (en) System for communicating with an implantable antenna
US20090187202A1 (en) Optimizing the operation of a restriction system
US8016744B2 (en) External pressure-based gastric band adjustment system and method
MXPA06007433A (en) Remote monitoring and adjustment of food intake restriction device.
US20120130273A1 (en) Non-Invasive Measurement Of Fluid Pressure In An Adjustable Gastric Band

Legal Events

Date Code Title Description
AS Assignment

Owner name: ETHICON ENDO-SURGERY, INC., OHIO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HASSLER, JR., WILLIAM L.;HOLSCHER, RUSSELL L.;PERRY, LAUREN S.;REEL/FRAME:017986/0651

Effective date: 20050224

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20230322